Chun-Wei Xu

Precision medicine of rare tumors: Uncovering the potential actionable targets through genomic profiling

Rare tumors constitute a substantial portion of cancer diagnoses, however, research remains limited. To assess the utility of genomic testing for informing treatment decisions, we retrospectively evaluated the landscape of actionable genomic alterations and immune biomarkers in rare tumors. Genomic and clinical data fr...